Cytokinetics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $463 | $249 | $835 | $1,672 |
Gross Profit | -84,149 | -2,157 | -1,496 | -4,663 |
EBITDA | -138,247 | -116,613 | -115,991 | -113,497 |
EBIT | -140,658 | -119,019 | -118,322 | -119,832 |
Net Income | -160,545 | -143,318 | -135,643 | -136,896 |
Net Change In Cash | 463 | 249 | 835 | 1,672 |
Free Cash Flow | -103,955 | -101,228 | -127,753 | -74,114 |
Cash | 46,888 | 190,517 | 120,351 | 113,399 |
Basic Shares | 117,685 | 109,240 | 101,924 | 99,067 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,530 | $94,588 | $70,428 | $55,828 |
Gross Profit | -322,593 | -146,225 | -89,510 | -41,123 |
EBITDA | -456,684 | -329,400 | -176,345 | -86,783 |
EBIT | -468,576 | -337,799 | -185,982 | -88,614 |
Net Income | -526,244 | -402,552 | -242,370 | -164,135 |
Net Change In Cash | 7,530 | 94,588 | 70,428 | 55,828 |
Cost of Revenue | -45,484 | 29,681 | 46,552 | |
Free Cash Flow | -415,749 | -310,851 | -191,394 | -2,109 |
Cash | 113,024 | 65,582 | 112,666 | 82,985 |
Basic Shares | 96,524 | 89,825 | 76,886 | 64,524 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.36 |
2024-06-30 | -$1.31 |
2024-03-31 | -$1.33 |
2023-12-31 | -$1.38 |
